Soung, J.; Tiu, L.; Veverka, K.; Hong, C.-H. Patient Preference for Calcipotriene 0.005%/Betamethasone Dipropionate 0.064% Foam or Topical Suspension Vs. Latest Topical Treatment in the PSO-INSIGHTFUL Study. J of Skin 2017, 1, s26.